Abundant progenitor cells in the adventitia contribute to atheroscleroses of vein grafts in ApoE-deficient mice

Journal of Clinical Investigation

Volumn 113, Issue 9, 2004, Pages 1258-1265

  Hu, Yanhua ^a   Zhang, Zhongyi ^a   Torsney, Evelyn ^a   Afzal, Ali R ^a   Davison, Fergus ^a   Metzler, Bernhard ^b   Xu, Qingbo ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ATAXIN 1; CD34 ANTIGEN; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; RECOMBINANT PROTEIN;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MARKER; EX VIVO STUDY; FIBROBLAST; GENE; GENETIC ENGINEERING; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTIMA; LACZ GENE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL; TISSUE; TISSUE CULTURE; TISSUE ENGINEERING; TRANSGENIC MOUSE; VASCULAR DISEASE; VEIN GRAFT; ALLOTRANSPLANTATION; ANIMAL; AORTA; ARTERIOSCLEROSIS; CAROTID ARTERY; CELL LINEAGE; CYTOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; RADIATION EXPOSURE; TIME; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE; VEIN;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS; STEM CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; VEINS;

EID: 85047694430     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19628     Document Type: Article

References (53)

1. Ross, R., Glomset, J., and Harker, L. 1977. Response to injury and atherogenesis. Am. J. Pathol. 86:675-684.
2. Saiura, A., Sata, M., Hirata, Y., Nagai, R., and Makuuchi, M. 2001. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 7:382-383.
3. Han, C.I., Campbell, G.R., and Campbell J.H. 2001. Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res. 38:113-119.
4. Shimizu, K., et al. 2001. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 7:738-741.
5. Hillebrands, J.L., et al. 2001. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J. Clin. Invest. 107:1411-1422.
6. Li, J., et al. 2001. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am. J. Pathol. 158:1943-1947.
7. Sata, M., et al. 2002. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8:403-409.
8. Hu, Y., et al. 2002. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation. 106:1834-1839.
9. Schwartz, S.M. 1999. The intima: a new soil. Circ. Res. 85:877-879.
10. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
11. Mayr, M., et al. 2000. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 14:261-270.
12. Simper, D., Stalboerger, P.G., Panetta, C.J., Wang, S., and Caplice, N.M. 2002. Smooth muscle progenitor cells in human blood. Circulation. 106:1199-1204.
13. Hu, Y., et al. 2002. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ. Res. 91:e13-e20.
14. Sata, M., et al. 2003. Origin of smooth muscle progenitor cells: different conclusions from different models. Response. Circulation. 107:106e-107e.
15. Tanaka, K., Sata, M., Hirata, Y., and Nagai, R. 2003. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ. Res. 93:783-790.
16. Shi, Y., et al. 1996. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 94:1655-1664.
17. Zalewski, A., and Shi, Y. 1997. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler. Thromb. Vasc. Biol. 17:417-422.
18. Sartore, S., et al. 2001. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ. Res. 89:1111-1121.
19. Rey, F.E., and Pagano, P.J. 2002. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler. Thromb. Vasc. Biol. 22:1962-1971.
20. Wilcox, J.N., Waksman, R., King, S.B., and Scott, N.A. 1996. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int. J. Radiat. Oncol. Biol. Phys. 36:789-796.
21. Shi, Y., et al. 1997. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation. 95:2684-2693.
22. Zou, Y., et al. 1998. Mouse model of venous bypass graft arteriosclerosis. Am. J. Pathol. 153:1301-1310.
23. Dietrich, H., et al. 2000. Rapid development of vein graft atheroma in ApoE-deficient mice. Am. J. Pathol. 157:659-669.
24. Terada, N., et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 416:542-545.
25. Wang, X., et al. 2003. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422:897-901.
26. Vassilopoulos, G., Wang, P.R., and Russell, D.W. 2003. Transplanted bone marrow regenerates liver by cell fusion. Nature. 422:901-904.
27. Vassilopoulos, G., and Russell, D.W. 2003. Cell fusion: an alternative to stem cell plasticity and its therapeutic implications. Curr. Opin. Genet. Dev. 13:480-485.
28. Hu, Y., Davison, F., Zhang, Z.G., and Xu, Q. 2003. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation. 108:3122-3127.
29. Xu, Q., Zhang, Z., Davison, P., and Hu, Y. 2003. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in apoE-deficient mice. Circ. Res. 93:e76-e86.
30. Dettman, R.W., Denetclaw, W., Jr., Ordahl, C.P., and Bristow, J. 1998. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev. Biol. 193:169-181.
31. Li, G., Chen, S.J., Oparil, S., Chen, Y.F., and Thompson, J.A. 2000. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation. 101:1362-1365.
32. De Leon, H., Ollerenshaw, J.D., Griendling, K.K., and Wilcox, J.N. 2001. Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation. 104:1591-1593.
33. Leitges, M., et al. 2001. Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice. J. Clin. Invest. 108:1505-1512. doi:10.1172/JCI200112902.
34. Mayr, M., Hu, Y., Hainaut, H., and Xu, Q. 2002. Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J. 16:1423-1425.
35. Mayr, U., et al. 2002. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ. Res. 90:197-204.
36. Campbell, J.H., and Campbell, G.R. 1994. The role of smooth muscle cells in atherosclerosis. Curr. Opin. Lipidol. 5:323-330.
37. Ross, R., and Glomset, J.A. 1976. The pathogenesis of atherosclerosis (first of two parts). N. Engl. J. Med. 295:369-377.
38. Ross, R., and Glomset, J.A. 1976. The pathogenesis of atherosclerosis (second of two parts). N. Engl. J. Med. 295:420-425.
39. Barrett, T.B., Sampson, P., Owens, G.K., Schwartz, S.M., and Benditt, E.P. 1983. Polyploid nuclei in human artery wall smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 80:882-885.
40. Goldberg, I.D., et al. 1984. Isolation and culture of a tetraploid subpopulation of smooth muscle cells from the normal rat aorta. Science. 226:559-561.
41. Owens, G.K. 1989. Growth response of tetraploid smooth muscle cells to balloon embolectomy-induced vascular injury in the spontaneously hypertensive rat. Am. Rev. Respir. Dis. 140:1467-1470.
42. Lin, Y., Weisdorf, D.J., Solovey, A., and Hebbel, R.P. 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105:71-77.
43. Rafii, S. 2000. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105:17-19.
44. Asahara, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964-967.
45. Crosby, J.R., et al. 2000. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 87:728-730.
46. Gunsilius, E., et al. 2000. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 355:1688-1691.
47. Yamashita, J., et al. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408:92-96.
48. Zambrowicz, B.P., et al. 1997. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 94:3789-3794.
49. Moessler, H., et al. 1996. The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development. 122:2415-2425.
50. Ludewig, B., et al. 2000. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. U. S. A. 97:12752-12757.
51. Hu, Y., Zou, Y., Dietrich, H., Wick, G., and Xu, Q. 1999. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation. 100:861-868.
52. Scopes, J., et al. 2001. Correction of stromal cell defect after bone marrow transplantation in aplastic anaemia. Br. J. Haematol. 115:642-652.
53. Hu, Y., Baker, A.H., Zou, Y., Newby, A.C., and Xu, Q. 2001. Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler. Thromb. Vasc. Biol. 21:1275-1280.